TreeWAS – Variant ID: rs35667974

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Chapter II Neoplasms	1.000	0.000	0.000
# Top node	1.000	0.000	0.000
Chapter X Diseases of the respiratory system	1.000	0.000	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.999	0.001	0.000
C44 Other malignant neoplasms of skin	0.999	0.001	0.000
Z51 Other medical care	0.999	0.001	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.997	0.003	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.996	0.004	0.000
Z51.0 Radiotherapy session	0.996	0.004	0.000
E03.9 Hypothyroidism, unspecified	0.000	0.005	0.995
C44.2 Skin of ear and external auricular canal	0.994	0.006	0.000
Z51.1 Chemotherapy session for neoplasm	0.993	0.007	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.991	0.008	0.001
E70-E90 Metabolic disorders	0.990	0.010	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.987	0.013	0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.986	0.014	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.984	0.016	0.000
Chapter I Certain infectious and parasitic diseases	0.978	0.022	0.000
J95-J99 Other diseases of the respiratory system	0.976	0.024	0.000
Chapter XX External causes of morbidity and mortality	0.975	0.025	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.972	0.028	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.968	0.032	0.000
J40-J47 Chronic lower respiratory diseases	0.968	0.032	0.000
Chapter XV Pregnancy, childbirth and the puerperium	0.962	0.038	0.000
A30-A49 Other bacterial diseases	0.961	0.039	0.000
K50-K52 Noninfective enteritis and colitis	0.961	0.039	0.000
K51 Ulcerative colitis	0.959	0.041	0.000
Y43 Primarily systemic agents	0.956	0.044	0.000
C79 Secondary malignant neoplasm of other sites	0.955	0.045	0.000
J45 Asthma	0.954	0.046	0.000
J98 Other respiratory disorders	0.954	0.046	0.000
Chapter XI Diseases of the digestive system	0.954	0.046	0.000
J45.9 Asthma, unspecified	0.951	0.049	0.000
D80-D89 Certain disorders involving the immune mechanism	0.950	0.050	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.949	0.051	0.000
Y43.3 Other antineoplastic drugs	0.945	0.055	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.945	0.055	0.000
A41 Other septicaemia	0.943	0.057	0.000
K51.9 Ulcerative colitis, unspecified	0.940	0.060	0.000
S20-S29 Injuries to the thorax	0.939	0.061	0.000
C60-C63 Malignant neoplasms of male genital organs	0.931	0.069	0.000
K52 Other non-infective gastro-enteritis and colitis	0.931	0.069	0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.930	0.070	0.000
Z51.5 Palliative care	0.929	0.071	0.000
Chapter XXI Factors influencing health status and contact with health services	0.926	0.074	0.000
Z40-Z54 Persons encountering health services for specific procedures and health care	0.924	0.076	0.000
C15-C26 Malignant neoplasms of digestive organs	0.924	0.076	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.924	0.076	0.000
J98.1 Pulmonary collapse	0.922	0.078	0.000
D00-D09 In situ neoplasms	0.921	0.079	0.000
J90-J94 Other diseases of pleura	0.919	0.081	0.000
Z51.3 Blood transfusion without reported diagnosis	0.917	0.083	0.000
C44.6 Skin of upper limb, including shoulder	0.913	0.087	0.000
E78.5 Hyperlipidaemia, unspecified	0.912	0.088	0.000
D70-D77 Other diseases of blood and blood-forming organs	0.906	0.094	0.000
E87.5 Hyperkalaemia	0.899	0.101	0.000
C44.3 Skin of other and unspecified parts of face	0.898	0.102	0.000
D86 Sarcoidosis	0.898	0.102	0.000
E83 Disorders of mineral metabolism	0.897	0.103	0.000
C85.1 B-cell lymphoma, unspecified	0.896	0.104	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.889	0.111	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.888	0.112	0.000
K52.9 Non-infective gastro-enteritis and colitis, unspecified	0.887	0.113	0.000
C43 Malignant melanoma of skin	0.877	0.123	0.000
C61 Malignant neoplasm of prostate	0.876	0.124	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.876	0.124	0.000
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.874	0.126	0.000
D03 Melanoma in situ	0.873	0.127	0.000
Z51.8 Other specified medical care	0.870	0.130	0.000
C44.7 Skin of lower limb, including hip	0.861	0.139	0.000
C51-C58 Malignant neoplasms of female genital organs	0.856	0.144	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.852	0.148	0.000
Chapter VIII Diseases of the ear and mastoid process	0.851	0.149	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.850	0.150	0.000
J00-J06 Acute upper respiratory infections	0.850	0.150	0.000
K70-K77 Diseases of liver	0.849	0.151	0.000
D70 Agranulocytosis	0.848	0.152	0.000
S00-S09 Injuries to the head	0.846	0.154	0.000
O60-O75 Complications of labour and delivery	0.844	0.156	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.843	0.157	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.841	0.159	0.000
J20-J22 Other acute lower respiratory infections	0.839	0.161	0.000
J98.8 Other specified respiratory disorders	0.839	0.161	0.000
Z51.2 Other chemotherapy	0.837	0.163	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.836	0.164	0.000
E87.3 Alkalosis	0.833	0.167	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.831	0.169	0.000
E87.6 Hypokalaemia	0.831	0.169	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.830	0.170	0.000
E20-E35 Disorders of other endocrine glands	0.830	0.170	0.000
A40 Streptococcal septicaemia	0.825	0.175	0.000
O20-O29 Other maternal disorders predominantly related to pregnancy	0.823	0.177	0.000
O48 Prolonged pregnancy	0.822	0.178	0.000
E86 Volume depletion	0.822	0.178	0.000
D86.0 Sarcoidosis of lung	0.819	0.181	0.000
S27 Injury of other and unspecified intrathoracic organs	0.818	0.182	0.000
E87.7 Fluid overload	0.818	0.182	0.000
B90-B94 Sequelae of infectious and parasitic diseases	0.815	0.185	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.814	0.186	0.000
E83.5 Disorders of calcium metabolism	0.812	0.188	0.000
Y57 Other and unspecified drugs and medicaments	0.811	0.189	0.000
J90 Pleural effusion, not elsewhere classified	0.810	0.190	0.000
J40 Bronchitis, not specified as acute or chronic	0.808	0.192	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.806	0.194	0.000
J46 Status asthmaticus	0.803	0.197	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.801	0.199	0.000
K51.2 Ulcerative (chronic) proctitis	0.800	0.200	0.000
O94-O99 Other obstetric conditions, not elsewhere classified	0.799	0.201	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.797	0.202	0.000
S20 Superficial injury of thorax	0.797	0.203	0.000
C83.3 Large cell (diffuse)	0.796	0.204	0.000
C88 Malignant immunoproliferative diseases	0.793	0.207	0.000
H65-H75 Diseases of middle ear and mastoid	0.793	0.207	0.000
C77.5 Intrapelvic lymph nodes	0.792	0.208	0.000
K51.8 Other ulcerative colitis	0.792	0.208	0.000
K50 Crohn's disease [regional enteritis]	0.792	0.208	0.000
E87.0 Hyperosmolality and hypernatraemia	0.792	0.208	0.000
K51.4 Pseudopolyposis of colon	0.789	0.211	0.000
S40-S49 Injuries to the shoulder and upper arm	0.788	0.212	0.000
T66-T78 Other and unspecified effects of external causes	0.786	0.214	0.000
K52.1 Toxic gastro-enteritis and colitis	0.784	0.216	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.784	0.216	0.000
B20-B24 Human immunodeficiency virus [HIV] disease	0.781	0.219	0.000
Z54 Convalescence	0.781	0.219	0.000
Z51.4 Preparatory care for treatment, not elsewhere classified	0.779	0.221	0.000
J93 Pneumothorax	0.779	0.221	0.000
T79-T79 Certain early complications of trauma	0.777	0.223	0.000
A80-A89 Viral infections of the central nervous system	0.777	0.223	0.000
D86.9 Sarcoidosis, unspecified	0.775	0.225	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.775	0.225	0.000
E73 Lactose intolerance	0.772	0.228	0.000
V40-V49 Car occupant injured in transport accident	0.772	0.228	0.000
C92 Myeloid leukaemia	0.772	0.228	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.771	0.229	0.000
S22 Fracture of rib(s), sternum and thoracic spine	0.770	0.230	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.769	0.231	0.000
A41.8 Other specified septicaemia	0.768	0.232	0.000
E00-E07 Disorders of thyroid gland	0.663	0.234	0.103
Y41 Other systemic anti-infectives and antiparasitics	0.766	0.234	0.000
B25-B34 Other viral diseases	0.764	0.236	0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.763	0.237	0.000
J06 Acute upper respiratory infections of multiple and unspecified sites	0.762	0.238	0.000
Y43.4 Immunosuppressive agents	0.760	0.240	0.000
S80-S89 Injuries to the knee and lower leg	0.760	0.240	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.758	0.241	0.000
A41.2 Septicaemia due to unspecified staphylococcus	0.755	0.245	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.754	0.246	0.000
J47 Bronchiectasis	0.754	0.246	0.000
K74 Fibrosis and cirrhosis of liver	0.753	0.247	0.000
E03 Other hypothyroidism	0.277	0.248	0.475
V10-V19 Pedal cyclist injured in transport accident	0.752	0.248	0.000
V80-V89 Other land transport accidents	0.750	0.250	0.000
C25 Malignant neoplasm of pancreas	0.748	0.251	0.000
C44.4 Skin of scalp and neck	0.748	0.252	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.747	0.253	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.746	0.253	0.000
C79.2 Secondary malignant neoplasm of skin	0.746	0.254	0.000
E83.4 Disorders of magnesium metabolism	0.744	0.256	0.000
W20-W49 Exposure to inanimate mechanical forces	0.744	0.256	0.000
E78.9 Disorder of lipoprotein metabolism, unspecified	0.743	0.257	0.000
C80 Malignant neoplasm without specification of site	0.742	0.258	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.740	0.260	0.000
D68 Other coagulation defects	0.739	0.261	0.000
C79.6 Secondary malignant neoplasm of ovary	0.739	0.261	0.000
D60-D64 Aplastic and other anaemias	0.737	0.263	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.736	0.264	0.000
O85-O92 Complications predominantly related to the puerperium	0.736	0.264	0.000
B15-B19 Viral hepatitis	0.735	0.265	0.000
Z43 Attention to artificial openings	0.734	0.266	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.732	0.267	0.000
D73 Diseases of spleen	0.732	0.268	0.000
C77.9 Lymph node, unspecified	0.731	0.269	0.000
C54 Malignant neoplasm of corpus uteri	0.730	0.270	0.000
C78.7 Secondary malignant neoplasm of liver	0.730	0.270	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.730	0.270	0.000
H65 Nonsuppurative otitis media	0.729	0.271	0.000
D80 Immunodeficiency with predominantly antibody defects	0.729	0.271	0.000
C81 Hodgkin's disease	0.729	0.271	0.000
C21 Malignant neoplasm of anus and anal canal	0.729	0.271	0.000
K52.3 Indeterminate colitis	0.727	0.273	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.727	0.273	0.000
O68 Labour and delivery complicated by foetal stress [distress]	0.726	0.274	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.726	0.274	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.726	0.274	0.000
Z70-Z76 Persons encountering health services in other circumstances	0.701	0.275	0.024
J22 Unspecified acute lower respiratory infection	0.724	0.276	0.000
S10-S19 Injuries to the neck	0.724	0.276	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.724	0.276	0.000
S29 Other and unspecified injuries of thorax	0.723	0.277	0.000
D06 Carcinoma in situ of cervix uteri	0.721	0.279	0.000
C43.5 Malignant melanoma of trunk	0.720	0.280	0.000
C78.0 Secondary malignant neoplasm of lung	0.717	0.283	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.717	0.283	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.717	0.283	0.000
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.717	0.283	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.716	0.284	0.000
C44.8 Overlapping lesion of skin	0.716	0.284	0.000
Z51.9 Medical care, unspecified	0.716	0.284	0.000
Z51.6 Desensitisation to allergens	0.716	0.284	0.000
C18 Malignant neoplasm of colon	0.716	0.284	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.715	0.285	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.715	0.285	0.000
C95 Leukaemia of unspecified cell type	0.715	0.285	0.000
C94 Other leukaemias of specified cell type	0.715	0.285	0.000
C93 Monocytic leukaemia	0.715	0.285	0.000
C86 Other specified types of T/NK-cell lymphoma	0.715	0.285	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.715	0.285	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.714	0.286	0.000
E40-E46 Malnutrition	0.713	0.286	0.001
S00 Superficial injury of head	0.713	0.287	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.711	0.289	0.000
E85 Amyloidosis	0.710	0.290	0.000
E84 Cystic fibrosis	0.710	0.290	0.000
E79 Disorders of purine and pyrimidine metabolism	0.710	0.290	0.000
E77 Disorders of glycoprotein metabolism	0.710	0.290	0.000
E76 Disorders of glycosaminoglycan metabolism	0.710	0.290	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.710	0.290	0.000
E74 Other disorders of carbohydrate metabolism	0.710	0.290	0.000
E72 Other disorders of amino-acid metabolism	0.710	0.290	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.710	0.290	0.000
E70 Disorders of aromatic amino-acid metabolism	0.710	0.290	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.710	0.290	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.708	0.292	0.000
C85.0 Lymphosarcoma	0.708	0.292	0.000
T33-T35 Frostbite	0.707	0.293	0.000
T26-T28 Burns and corrosions confined to eye and internal organs	0.707	0.293	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.707	0.293	0.000
T00-T07 Injuries involving multiple body regions	0.707	0.293	0.000
Z48 Other surgical follow-up care	0.706	0.294	0.000
D55-D59 Haemolytic anaemias	0.706	0.294	0.000
T15-T19 Effects of foreign body entering through natural orifice	0.705	0.294	0.000
J81 Pulmonary oedema	0.704	0.296	0.000
J09-J18 Influenza and pneumonia	0.704	0.296	0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.702	0.298	0.000
B99-B99 Other infectious diseases	0.701	0.299	0.000
B85-B89 Pediculosis, acariasis and other infestations	0.701	0.299	0.000
B65-B83 Helminthiases	0.701	0.299	0.000
B50-B64 Protozoal diseases	0.701	0.299	0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.701	0.299	0.000
A75-A79 Rickettsioses	0.701	0.299	0.000
A70-A74 Other diseases caused by chlamydiae	0.701	0.299	0.000
A65-A69 Other spirochaetal diseases	0.701	0.299	0.000
A20-A28 Certain zoonotic bacterial diseases	0.701	0.299	0.000
A15-A19 Tuberculosis	0.701	0.299	0.000
Y52 Agents primarily affecting the cardiovascular system	0.701	0.299	0.000
J99 Respiratory disorders in diseases classified elsewhere	0.700	0.300	0.000
J96 Respiratory failure, not elsewhere classified	0.700	0.300	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.700	0.300	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.699	0.301	0.000
Y35-Y36 Legal intervention and operations of war	0.699	0.301	0.000
Y10-Y34 Event of undetermined intent	0.699	0.301	0.000
Y00-Y09 Assault	0.699	0.301	0.000
X85-X99 Assault	0.699	0.301	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.699	0.301	0.000
X50-X57 Overexertion, travel and privation	0.699	0.301	0.000
X30-X39 Exposure to forces of nature	0.699	0.301	0.000
X20-X29 Contact with venomous animals and plants	0.699	0.301	0.000
X10-X19 Contact with heat and hot substances	0.699	0.301	0.000
X00-X09 Exposure to smoke, fire and flames	0.699	0.301	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.699	0.301	0.000
W75-W84 Other accidental threats to breathing	0.699	0.301	0.000
W65-W74 Accidental drowning and submersion	0.699	0.301	0.000
W50-W64 Exposure to animate mechanical forces	0.699	0.301	0.000
V98-V99 Other and unspecified transport accidents	0.699	0.301	0.000
V95-V97 Air and space transport accidents	0.699	0.301	0.000
V90-V94 Water transport accidents	0.699	0.301	0.000
V70-V79 Bus occupant injured in transport accident	0.699	0.301	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.699	0.301	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.699	0.301	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.699	0.301	0.000
V01-V09 Pedestrian injured in transport accident	0.699	0.301	0.000
J06.9 Acute upper respiratory infection, unspecified	0.699	0.301	0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.698	0.302	0.000
O43 Placental disorders	0.698	0.302	0.000
B91 Sequelae of poliomyelitis	0.697	0.303	0.000
E87.4 Mixed disorder of acid-base balance	0.697	0.303	0.000
H60-H62 Diseases of external ear	0.697	0.303	0.000
H73 Other disorders of tympanic membrane	0.697	0.303	0.000
C62 Malignant neoplasm of testis	0.695	0.305	0.000
C20 Malignant neoplasm of rectum	0.694	0.306	0.000
O42 Premature rupture of membranes	0.694	0.306	0.000
Y59 Other and unspecified vaccines and biological substances	0.694	0.306	0.000
Y58 Bacterial vaccines	0.694	0.306	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.694	0.306	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.694	0.306	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.694	0.306	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.694	0.306	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.694	0.306	0.000
Y48 Anaesthetics and therapeutic gases	0.694	0.306	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.694	0.306	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.694	0.306	0.000
J41 Simple and mucopurulent chronic bronchitis	0.694	0.306	0.000
K81 Cholecystitis	0.694	0.306	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.693	0.307	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.693	0.307	0.000
S27.0 Traumatic pneumothorax	0.693	0.307	0.000
O62 Abnormalities of forces of labour	0.693	0.307	0.000
O64 Obstructed labour due to malposition and malpresentation of foetus	0.693	0.307	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.693	0.307	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.692	0.307	0.000
A48 Other bacterial diseases, not elsewhere classified	0.689	0.311	0.000
A44 Bartonellosis	0.689	0.311	0.000
A43 Nocardiosis	0.689	0.311	0.000
A42 Actinomycosis	0.689	0.311	0.000
A39 Meningococcal infection	0.689	0.311	0.000
A37 Whooping cough	0.689	0.311	0.000
A36 Diphtheria	0.689	0.311	0.000
A32 Listeriosis	0.689	0.311	0.000
A31 Infection due to other mycobacteria	0.689	0.311	0.000
A30 Leprosy [Hansen's disease]	0.689	0.311	0.000
A46 Erysipelas	0.689	0.311	0.000
A38 Scarlet fever	0.689	0.311	0.000
A35 Other tetanus	0.689	0.311	0.000
A34 Obstetrical tetanus	0.689	0.311	0.000
A33 Tetanus neonatorum	0.689	0.311	0.000
Chapter XXII Codes for special purposes	0.689	0.311	0.000
S06 Intracranial injury	0.689	0.311	0.000
C45 Mesothelioma	0.689	0.311	0.000
Y40 Systemic antibiotics	0.688	0.312	0.000
K51.5 Mucosal proctocolitis	0.687	0.313	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.687	0.313	0.000
Y43.9 Primarily systemic agent, unspecified	0.685	0.314	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.685	0.314	0.000
Y43.6 Enzymes, not elsewhere classified	0.685	0.314	0.000
Y43.5 Acidifying and alkalising agents	0.685	0.314	0.000
Y43.2 Antineoplastic natural products	0.685	0.314	0.000
Y43.1 Antineoplastic antimetabolites	0.685	0.314	0.000
Y43.0 Antiallergic and antiemetic drugs	0.685	0.314	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.685	0.315	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.685	0.315	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.685	0.315	0.000
J45.8 Mixed asthma	0.684	0.316	0.000
J45.1 Nonallergic asthma	0.684	0.316	0.000
J98.9 Respiratory disorder, unspecified	0.684	0.316	0.000
J98.6 Disorders of diaphragm	0.684	0.316	0.000
J98.5 Diseases of mediastinum, not elsewhere classified	0.684	0.316	0.000
J98.3 Compensatory emphysema	0.684	0.316	0.000
J98.2 Interstitial emphysema	0.684	0.316	0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.684	0.316	0.000
K72 Hepatic failure, not elsewhere classified	0.684	0.316	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.683	0.317	0.000
V20-V29 Motorcycle rider injured in transport accident	0.683	0.317	0.000
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.682	0.318	0.000
D84 Other immunodeficiencies	0.681	0.318	0.000
D83 Common variable immunodeficiency	0.681	0.318	0.000
D82 Immunodeficiency associated with other major defects	0.681	0.318	0.000
D81 Combined immunodeficiencies	0.681	0.318	0.000
A40.3 Septicaemia due to Streptococcus pneumoniae	0.681	0.319	0.000
J98.4 Other disorders of lung	0.681	0.319	0.000
C77.3 Axillary and upper limb lymph nodes	0.680	0.320	0.000
C16 Malignant neoplasm of stomach	0.679	0.321	0.000
Z54.0 Convalescence following surgery	0.679	0.321	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.677	0.323	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.677	0.323	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.677	0.323	0.000
K81.9 Cholecystitis, unspecified	0.677	0.323	0.000
K50.9 Crohn's disease, unspecified	0.677	0.323	0.000
A41.4 Septicaemia due to anaerobes	0.676	0.324	0.000
A41.3 Septicaemia due to Haemophilus influenzae	0.676	0.324	0.000
A41.0 Septicaemia due to Staphylococcus aureus	0.676	0.324	0.000
J93.8 Other pneumothorax	0.676	0.324	0.000
O23 Infections of genito-urinary tract in pregnancy	0.675	0.324	0.000
Y44 Agents primarily affecting blood constituents	0.674	0.326	0.000
C83.0 Small cell (diffuse)	0.674	0.326	0.000
K75 Other inflammatory liver diseases	0.674	0.326	0.000
E22 Hyperfunction of pituitary gland	0.674	0.326	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.674	0.326	0.000
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.673	0.327	0.000
S26 Injury of heart	0.673	0.327	0.000
S25 Injury of blood vessels of thorax	0.673	0.327	0.000
S24 Injury of nerves and spinal cord at thorax level	0.673	0.327	0.000
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.673	0.327	0.000
S21 Open wound of thorax	0.673	0.327	0.000
S70-S79 Injuries to the hip and thigh	0.673	0.327	0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.673	0.327	0.000
X60-X84 Intentional self-harm	0.672	0.328	0.000
J92 Pleural plaque	0.672	0.328	0.000
S60-S69 Injuries to the wrist and hand	0.671	0.329	0.000
C77.8 Lymph nodes of multiple regions	0.671	0.329	0.000
B35-B49 Mycoses	0.671	0.329	0.000
Y57.9 Drug or medicament, unspecified	0.671	0.329	0.000
E78.2 Mixed hyperlipidaemia	0.670	0.329	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.667	0.332	0.000
C60 Malignant neoplasm of penis	0.667	0.332	0.000
E83.3 Disorders of phosphorus metabolism	0.667	0.333	0.000
K52.2 Allergic and dietetic gastro-enteritis and colitis	0.667	0.333	0.000
K52.0 Gastro-enteritis and colitis due to radiation	0.667	0.333	0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.667	0.333	0.000
A40.8 Other streptococcal septicaemia	0.667	0.333	0.000
E78.8 Other disorders of lipoprotein metabolism	0.667	0.333	0.000
E78.6 Lipoprotein deficiency	0.667	0.333	0.000
E78.4 Other hyperlipidaemia	0.667	0.333	0.000
E78.3 Hyperchylomicronaemia	0.667	0.333	0.000
E78.1 Pure hyperglyceridaemia	0.667	0.333	0.000
D04 Carcinoma in situ of skin	0.667	0.333	0.000
C77.1 Intrathoracic lymph nodes	0.666	0.334	0.000
J84 Other interstitial pulmonary diseases	0.666	0.334	0.000
C91 Lymphoid leukaemia	0.666	0.334	0.000
O21 Excessive vomiting in pregnancy	0.666	0.334	0.000
O41 Other disorders of amniotic fluid and membranes	0.663	0.336	0.000
C77.4 Inguinal and lower limb lymph nodes	0.663	0.337	0.000
Z44 Fitting and adjustment of external prosthetic device	0.662	0.337	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.662	0.338	0.000
C17 Malignant neoplasm of small intestine	0.662	0.338	0.000
C23 Malignant neoplasm of gallbladder	0.662	0.338	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.662	0.338	0.000
C53 Malignant neoplasm of cervix uteri	0.662	0.338	0.000
J94 Other pleural conditions	0.660	0.340	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.660	0.340	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.660	0.340	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.660	0.340	0.000
O35 Maternal care for known or suspected foetal abnormality and damage	0.660	0.340	0.000
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.660	0.340	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.659	0.340	0.000
H65.3 Chronic mucoid otitis media	0.659	0.341	0.000
O73 Retained placenta and membranes, without haemorrhage	0.659	0.341	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.658	0.342	0.000
K81.1 Chronic cholecystitis	0.657	0.343	0.000
S27.1 Traumatic haemothorax	0.657	0.343	0.000
C78.2 Secondary malignant neoplasm of pleura	0.657	0.343	0.000
A50-A64 Infections with a predominantly sexual mode of transmission	0.657	0.343	0.000
Z52 Donors of organs and tissues	0.655	0.344	0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.646	0.345	0.009
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.654	0.346	0.000
S20.2 Contusion of thorax	0.654	0.346	0.000
S50-S59 Injuries to the elbow and forearm	0.654	0.346	0.000
S05 Injury of eye and orbit	0.653	0.347	0.000
Y54.3 Benzothiadiazine derivatives	0.652	0.348	0.000
S80 Superficial injury of lower leg	0.652	0.348	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.651	0.348	0.000
E88 Other metabolic disorders	0.651	0.349	0.000
E24 Cushing's syndrome	0.651	0.349	0.000
J91 Pleural effusion in conditions classified elsewhere	0.650	0.350	0.000
K74.6 Other and unspecified cirrhosis of liver	0.650	0.350	0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system	0.649	0.350	0.000
D74 Methaemoglobinaemia	0.649	0.350	0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere	0.649	0.350	0.000
D71 Functional disorders of polymorphonuclear neutrophils	0.649	0.350	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.649	0.350	0.000
C18.9 Colon, unspecified	0.648	0.352	0.000
S22.4 Multiple fractures of ribs	0.648	0.352	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.647	0.353	0.000
J98.0 Diseases of bronchus, not elsewhere classified	0.645	0.355	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.645	0.355	0.000
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.644	0.356	0.000
C55 Malignant neoplasm of uterus, part unspecified	0.644	0.356	0.000
B25 Cytomegaloviral disease	0.644	0.356	0.000
T80-T88 Complications of surgical and medical care, not elsewhere classified	0.644	0.356	0.000
S09 Other and unspecified injuries of head	0.644	0.356	0.000
D86.8 Sarcoidosis of other and combined sites	0.644	0.356	0.000
D86.3 Sarcoidosis of skin	0.644	0.356	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.644	0.356	0.000
D86.1 Sarcoidosis of lymph nodes	0.644	0.356	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.643	0.357	0.000
E83.8 Other disorders of mineral metabolism	0.643	0.357	0.000
E83.2 Disorders of zinc metabolism	0.643	0.357	0.000
E83.0 Disorders of copper metabolism	0.643	0.357	0.000
S90-S99 Injuries to the ankle and foot	0.642	0.357	0.000
T78 Adverse effects, not elsewhere classified	0.642	0.358	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.641	0.358	0.000
C77.2 Intra-abdominal lymph nodes	0.641	0.359	0.000
C54.1 Endometrium	0.640	0.360	0.000
J60-J70 Lung diseases due to external agents	0.640	0.360	0.000
B24 Unspecified human immunodeficiency virus [HIV] disease	0.640	0.360	0.000
E28 Ovarian dysfunction	0.638	0.361	0.000
O66 Other obstructed labour	0.639	0.361	0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.638	0.362	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.637	0.363	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.637	0.363	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.637	0.363	0.000
C83.7 Burkitt's tumour	0.637	0.363	0.000
C83.6 Undifferentiated (diffuse)	0.637	0.363	0.000
C83.5 Lymphoblastic (diffuse)	0.637	0.363	0.000
C83.4 Immunoblastic (diffuse)	0.637	0.363	0.000
C83.2 Mixed small and large cell (diffuse)	0.637	0.363	0.000
C83.1 Small cleaved cell (diffuse)	0.637	0.363	0.000
S20.8 Superficial injuries of other and unspecified parts of thorax	0.636	0.364	0.000
O69 Labour and delivery complicated by umbilical cord complications	0.636	0.364	0.000
D09 Carcinoma in situ of other and unspecified sites	0.635	0.365	0.000
J04 Acute laryngitis and tracheitis	0.633	0.367	0.000
A86 Unspecified viral encephalitis	0.632	0.368	0.000
S02 Fracture of skull and facial bones	0.630	0.370	0.000
C44.1 Skin of eyelid, including canthus	0.629	0.371	0.000
J80 Adult respiratory distress syndrome	0.629	0.371	0.000
C43.9 Malignant melanoma of skin, unspecified	0.629	0.371	0.000
C43.8 Overlapping malignant melanoma of skin	0.629	0.371	0.000
C43.4 Malignant melanoma of scalp and neck	0.629	0.371	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.629	0.371	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.629	0.371	0.000
C43.0 Malignant melanoma of lip	0.629	0.371	0.000
C92.0 Acute myeloid leukaemia	0.629	0.371	0.000
H73.8 Other specified disorders of tympanic membrane	0.629	0.371	0.000
E27 Other disorders of adrenal gland	0.628	0.371	0.000
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.628	0.371	0.000
E23 Hypofunction and other disorders of pituitary gland	0.628	0.372	0.000
Z49 Care involving dialysis	0.628	0.372	0.000
T79 Certain early complications of trauma, not elsewhere classified	0.628	0.372	0.000
Y57.5 X-ray contrast media	0.627	0.372	0.000
W00-W19 Falls	0.627	0.373	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations